DIMENSIONAL FUND ADVISORS LP 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:59 am Sale | 2024-02-14 | 13G | Lifecore Biomedical, Inc. LFCR | DIMENSIONAL FUND ADVISORS LP | 1,940 0.000% | -1,755,604 (-99.89%) | Filing |
| 2023-02-10 2:42 pm Sale | 2023-02-14 | 13G | Lifecore Biomedical, Inc. LFCR | DIMENSIONAL FUND ADVISORS LP | 1,757,544 5.900% | -216,064 (-10.95%) | Filing |
| 2022-02-08 3:52 pm Sale | 2022-02-14 | 13G | Lifecore Biomedical, Inc. LFCR | DIMENSIONAL FUND ADVISORS LP | 1,973,608 6.700% | -245,753 (-11.07%) | Filing |
| 2021-02-12 5:13 pm Sale | 2021-02-16 | 13G | Lifecore Biomedical, Inc. LFCR | DIMENSIONAL FUND ADVISORS LP | 2,219,361 7.600% | -212,172 (-8.73%) | Filing |